It increases carbon monoxide levels in the bloodstream, which lowers the oxygen available to tissues. Doctors often recommend stricter monitoring schedules for these patients to lower the chance of dangerous events. For men who already have heart disease or clogged arteries, this extra blood thickness can strain the cardiovascular system. These changes can make the body more likely to react strongly to testosterone. The most important part of managing polycythemia is ongoing medical care. These changes may not replace medical treatments, but they support them and improve overall safety. This is a procedure similar to donating blood, where about a pint (500 mL) of blood is removed from the body. Thick blood does not flow as easily, and this increases the chance of blood clots, strokes, and heart problems. Some men may notice warning symptoms like headaches or dizziness, but others may have no signs until a major health event occurs. If polycythemia continues without treatment, chronic organ stress can lead to long-term harm. These complications can develop silently at first, making regular monitoring critical. Thicker blood and clot risk together increase the strain on the cardiovascular system. Testosterone therapy can improve energy, muscle mass, mood, and sexual health. Prevention works best when patients and doctors work together. This means removing a unit of blood, similar to a blood donation, to bring hematocrit back down. A hematocrit over 52–54% is considered too high and may require changes in treatment. Your risk of developing polycythemia may increase if you have any of these conditions and also begin Testosterone Replacement Therapy. You and your provider should continue measuring your hematocrit and hemoglobin after beginning therapeutic phlebotomy. Healthy patients who are eligible to donate blood can take this route. Removing one pint of blood generally lowers hematocrit by around 3% (results vary by patient). Therapeutic phlebotomy is similar to donating blood, but this procedure is prescribed by physicians as a way to bring down blood hematocrit and viscosity. Many patients don’t like this option, either, because their injection protocol is effective at reducing their hormone imbalance symptoms. Once TRT begins, the monitoring schedule becomes a pivotal element in the patient’s care plan. Baseline measurements are also essential for identifying pre-existing conditions that might be exacerbated by TRT, such as latent polycythemia. The journey to managing polycythemia effectively begins before the initiation of TRT. These indicators are crucial for diagnosing polycythemia, understanding its implications, and implementing timely and effective management strategies. It’s not just about the numbers but how they fit into the broader picture of the patient’s health.